|
1
|
Day CP: Non-alcoholic fatty liver disease:
current concepts and management strategies. Clin Med. 6:19–25.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang S, Zhu H, Li Y, et al: Mitochondrial
adaptations to obesity related oxidant stress. Arch Biochem
Biophys. 378:259–268. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Madan K, Bhardwaj P, Thareja S, Gupta SD
and Saraya A: Oxidant stress and antioxidant status among patients
with nonalcoholic fatty liver disease (NAFLD). J Clin
Gastroenterol. 40:930–935. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Browning JD and Horton JD: Molecular
mediators of hepatic steatosis and liver injury. J Clin Invest.
114:147–152. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Narasimhan S, Gokulakrishnan K,
Sampathkumar R, et al: Oxidative stress is independently associated
with non-alcoholic fatty liver disease (NAFLD) in subjects with and
without type 2 diabetes. Clin Biochem. 43:815–821. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stangl R, Szijártó A, Ónody P, et al:
Reduction of liver ischemia-reperfusion injury via glutamine
pretreatment. J Surg Res. 166:95–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang WX, Zhou LF, Zhang L, et al:
Protective effects of glutamine preconditioning on
ischemia-reperfusion injury in rats. Hepatobiliary Pancreat Dis
Int. 10:78–82. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng HC, Chen YL, Chen JR, et al: Effects
of glutamine administration on inflammatory responses in chronic
ethanol-fed rats. J Nutr Biochem. 22:282–288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kessel A, Toubi E, Pavlotzky E, et al:
Treatment with glutamine is associated with down-regulation of
Toll-like receptor-4 and myeloid differentiation factor 88
expression and decrease in intestinal mucosal injury caused by
lipopolysaccharide endotoxaemia in a rat. Clin Exp Immunol.
151:341–347. 2008. View Article : Google Scholar
|
|
10
|
Kul M, Vurucu S, Demirkaya E, et al:
Enteral glutamine and/or arginine supplementation have favorable
effects on oxidative stress parameters in neonatal rat intestine. J
Pediatr Gastroenterol Nutr. 49:85–89. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tsai PH, Liu JJ, Chiu WC, Pai MH and Yeh
SL: Effects of dietary glutamine on adhesion molecule expression
and oxidative stress in mice with streptozotocin-induced type 1
diabetes. Clin Nutr. 30:124–129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
El-Sheikh NM and Khalil FA: L-arginine and
L-glutamine as immunonutrients and modulating agents for oxidative
stress and toxicity induced by sodium nitrite in rats. Food Chem
Toxicol. 49:758–762. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim H: Glutamine as an immunonutrient.
Yonsei Med J. 52:892–897. 2011. View Article : Google Scholar
|
|
14
|
Adams LA and Angulo P: Treatment of
non-alcoholic fatty liver disease. Postgrad Med J. 82:315–322.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu JC, Jiang ZM and Li DM: Glutamine: a
precursor of glutathione and its effect on liver. World J
Gastroenterol. 5:143–146. 1999.PubMed/NCBI
|
|
16
|
Tihan DN, Erbil Y, Seven R, et al: The
effect of glutamine on oxidative damage in an experimental
abdominal compartment syndrome model in rats. Ulus Trauma Acil
Cerrahi Derg. 17:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park HJ, DiNatale DA, Chung MY, et al:
Green tea extract attenuates hepatic steatosis by decreasing
adipose lipogenesis and enhancing hepatic antioxidant defenses in
ob/ob mice. J Nutr Biochem. 22:393–400. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hardwick RN, Fisher CD, Canet MJ, Lake AD
and Cherrington NJ: Diversity in antioxidant response enzymes in
progressive stages of human nonalcoholic fatty liver disease. Drug
Metab Dispos. 38:2293–2301. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee YM, Sutedja DS, Wai CT, et al: A
randomized controlled pilot study of Pentoxifylline in patients
with non-alcoholic steatohepatitis (NASH). Hepatol Int. 2:196–201.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tilg H: The role of cytokines in
non-alcoholic fatty liver disease. Dig Dis. 28:179–185. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tsai PH, Yeh CL, Liu JJ, Chiu WC and Yeh
SL: Effects of dietary glutamine on inflammatory mediator gene
expressions in rats with streptozotocin-induced diabetes.
Nutrition. 28:288–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jang HJ, Kwak JH, Cho EY, et al: Glutamine
induces heat-shock protein-70 and glutathione expression and
attenuates ischemic damage in rat islets. Transplant Proc.
40:2581–2584. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pai MH, Chien YW, Tsai YH, Hu YM and Yeh
SL: Glutamine reduces the expression of leukocyte integrins
leukocyte function-associated antigen-1 and macrophage antigen-1 in
mice exposed to arsenic. Nutr Res. 28:544–549. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kaplowitz N and Tsukamoto H: Oxidative
stress and liver disease. Prog Liver Dis. 14:131–159.
1996.PubMed/NCBI
|
|
25
|
Videla LA, Tapia G, Rodrigo R, et al:
Liver NF-kappa B and AP-1 DNA binding in obese patients. Obesity
(Silver Spring). 17:973–979. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dela Peña A, Leclercq I, Field J, George
J, Jones B and Farrell G: NF-kappaB activation, rather than TNF,
mediates hepatic inflammation in a murine dietary model of
steatohepatitis. Gastroenterology. 129:1663–1674. 2005.PubMed/NCBI
|
|
27
|
Cai D, Yuan M, Frantz DF, Melendez PA,
Hansen L, Lee J and Shoelson SE: Local and systemic insulin
resistance resulting from hepatic activation of IKK-beta and
NF-kappaB. Nat Med. 11:183–190. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Singleton KD, Beckey VE and Wischmeyer PE:
Glutamine prevents activation of NF-kappa B and stress kinase
pathways, attenuates inflammatory cytokine release, and prevents
acute respiratory distress syndrome (ARDS) following sepsis. Shock.
24:583–589. 2005. View Article : Google Scholar
|
|
29
|
Singleton KD and Wischmeyer PE:
Glutamine’s protection against sepsis and lung injury is dependent
on heat shock protein 70 expression. Am J Physiol Regul Integr Comp
Physiol. 292:R1839–R1845. 2007.
|
|
30
|
Huang Y, Li N, Liboni K and Neu J:
Glutamine decreases lipopolysaccharide-induced IL-8 production in
Caco-2 cells through a non-NF-kappaB p50 mechanism. Cytokine.
22:77–83. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fan JG, Qian Y, Zheng XY, Cai XB and Lu
YS: Effects of pentoxifyiline on hepatic nuclear factor-kappa B
signaling pathway and insulin resistance in nonalcoholic
steatohepatitis rats induced by fat-rich diet. Zhonghua Gan Zang
Bing Za Zhi. 14:762–766. 2006.(In Chinese).
|
